The hypothesis that Helicobacter pylori predisposes to Alzheimer's disease is biologically plausible

Felice Contaldi1, Federico Capuano2, Andrea Fulgione1

  • 1Department of Agriculture, University of Naples "Federico II", Portici, 80055, Italy.

Scientific Reports
|August 12, 2017
PubMed

Insights

Helicobacter pylori peptide Hp(2-20) exposure in human cells activates genes linked to Alzheimer's disease and inflammation. This suggests a potential cellular mechanism connecting H. pylori infection to neurodegenerative disease risk.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Microbiology

Background:

  • Epidemiological studies suggest a correlation between Helicobacter pylori (H. pylori) infection and an increased risk of developing Alzheimer's disease.
  • The specific cellular and molecular mechanisms underlying this potential link remain largely unexplored.

Purpose of the Study:

  • To investigate the cellular response to H. pylori peptide Hp(2-20) exposure in human gastric cells.
  • To identify genes and pathways modulated by Hp(2-20) that may bridge H. pylori infection and Alzheimer's disease pathology.

Main Methods:

  • Incubation of human gastric MNK-28 cells with the H. pylori peptide Hp(2-20).
  • Global gene expression analysis to monitor changes in gene activation.
  • Bioinformatic analysis to identify modulated genes and associated pathways, including cross-referencing with the AlzBase database.

Main Results:

  • Hp(2-20) modulated 77 genes in MNK-28 cells.
  • A significant proportion (65 genes) of modulated genes are listed in the AlzBase database, including key Alzheimer's disease genes: APP, APOE, PSEN1, and PSEN2.
  • Thirty of the 77 modulated genes were associated with the inflammation pathway, indicating a strong inflammatory response.

Conclusions:

  • The H. pylori peptide Hp(2-20) significantly impacts gene expression in human gastric cells, affecting genes central to Alzheimer's disease.
  • The observed dysregulation of pathways, including inflammation, mirrors those seen in Alzheimer's and Leasch-Nyhan diseases.
  • These findings propose a novel, albeit preliminary, cellular link between H. pylori infection and the pathogenesis of neurological disorders like Alzheimer's disease, warranting further investigation.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
932
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.3K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
682